PREPRINT (not peer reviewed)

Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: bioRxiv
Date: 2023-10-07
Source: bioRxiv
DOI: 10.1101/2023.10.06.561183
PubMed: Unavailable

Authors

Shinozuka K Jerotic K Mediano P Zhao AT Preller KH Carhart-Harris R Kringelbach ML.

Watch author

Derived topics and classifications

psilocybin psilocin Depression Addiction Brain Imaging Pharmacology Receptor Pharmacology Consciousness Aging Systematic Review Review Article Safety Systematic Review

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psilocybin therapy: A novel approach to treating depressionInternational Journal of Surgery Global Health · 2023-06-02 Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05 Psilocybin Administration With 5-HT1a BlockadeClinicalTrials.gov · 2026-08-14 PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin PretreatmentClinicalTrials.gov · 2026-07-21 Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and EfficacyClinicalTrials.gov · 2026-06-22 Characterization of Altered Waking States of Consciousness in Healthy HumansClinicalTrials.gov · 2021-04-29 Effects of Psilocybin on Electrophysiology and the Dynamic Content of ThoughtClinicalTrials.gov · 2026-07-23 Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's DiseaseClinicalTrials.gov · 2026-03-16